Neola Medical AB (publ)

OM:NEOLA Stock Report

Market Cap: SEK 202.0m

Neola Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:NEOLA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Sep 24SellSEK 119,581Hanna SjostromIndividual37,369SEK 3.20
16 Aug 24SellSEK 78,714Hanna SjostromIndividual26,567SEK 3.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NEOLA?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,013,5555.72%
VC/PE Firms5,528,9677.88%
Private Companies14,359,85820.5%
Individual Insiders18,047,28625.7%
General Public28,200,56840.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 17 shareholders own 59.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.5%
Anmiro AB
14,359,858SEK 41.4m0%no data
18.9%
Pär Josefsson
13,250,023SEK 38.2m0%no data
7.88%
LMK Forward AB
5,528,967SEK 15.9m0%17.58%
3.44%
Cardeon AB (publ)
2,412,887SEK 6.9m0%47.75%
2.94%
Bengt Nevsten
2,062,914SEK 5.9m0%no data
1.37%
Avanza Fonder AB
958,982SEK 2.8m0%no data
0.91%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
636,963SEK 1.8m0%0.03%
0.89%
Magnus Kenneby
625,000SEK 1.8m0%no data
0.83%
Urban Ottosson
584,240SEK 1.7m0%no data
0.78%
Marcus Kolskog
546,600SEK 1.6m0%no data
0.55%
Tommy Hedberg
384,616SEK 1.1m0%no data
0.34%
Hanna Sjostrom
239,840SEK 690.7k0%no data
0.21%
Sara Bergsten
145,843SEK 420.0k0%no data
0.19%
Marta Xu
134,210SEK 386.5k0%no data
0.071%
Mattias Lundin
50,000SEK 144.0k0%no data
0.034%
Magnus Johnsson
24,000SEK 69.1k0%no data
0.0067%
FCG Fonder AB
4,723SEK 13.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 07:53
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neola Medical AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gustaf MeyerRedeye